Oral mucositis, pain and xerostomia in 135 head and neck cancer patients receiving radiotherapy with or without chemotherapy

Open Cancer Journal

Volumn 4, Issue 1, 2011, Pages 7-17

  Nicolatou Galitis, Ourania ^a   Kouloulias, Vassilis ^b   Sotiropoulou Lountou, Anastasia ^c   Dardoufas, Konstantinos ^d   Polychronopoulou, Argyro ^a   Athanassiadou, Pavlina ^e   Kolitsi, Georgia ^d   Kouvaris, John ^f  

^a UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c SAINT SAVVAS HOSPITAL   (Greece)

^d HYGEIA HOSPITAL   (Greece)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^f UNIVERSITY OF ATHENS   (Greece)

Author keywords

Antifungal and antiviral treatment; Head and neck radiotherapy; Oral mucositis; Pain; Xerostomia

Indexed keywords

ACICLOVIR; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CETUXIMAB; CISPLATIN; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; VALACICLOVIR;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; CYTOLOGY; DERMATITIS; DISEASE SEVERITY; FATIGUE; FEMALE; FEVER; HEAD AND NECK CANCER; HERPES LABIALIS; HERPETIC STOMATITIS; HISTOPATHOLOGY; HUMAN; INFECTION PREVENTION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; MOUTH PAIN; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; PLASMACYTOMA; PREVALENCE; PRIORITY JOURNAL; RADIATION DOSE; SALIVARY ADENOCARCINOMA; SELF EVALUATION; SQUAMOUS CELL CARCINOMA; SYMPTOMATOLOGY; THRUSH; TONGUE ULCER; WEIGHT CHANGE; XEROSTOMIA;

EID: 80053550921     PISSN: None     EISSN: 18740790     Source Type: Journal    
DOI: 10.2174/1874079001104010007     Document Type: Article

References (33)

1. Spijkervet FKL, Van Saene HKF, Panders AK, Vermey A, Mehta DM. Scoring irradiation mucositis in head and neck cancer patients. J Oral Pathol Med 1989; 18: 167-71.
2. Ohrn KEO, Wahlin YB, Sjoden PO. Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications. Support Care Cancer 2001; 9: 247-57.
3. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003; 66: 253-62.
4. Epstein JB, Beaumont JL, Gwede CK, et al. Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Cancer 2007; 109: 1914-22.
5. Elting LS, Keefe DM, Sonis ST, et al. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy. Cancer 2008; 113: 2704-13.
6. Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 2007; 68: 1110-20.
7. Nonzee NJ, Dandade NA, Markossiant T, et al. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis. Cancer 2008; 113: 1446-52.
8. Vera-Llonch M, Oster G, Hagiwara M, Sonis ST. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Risk factors and clinical consequences. Cancer 2006; 106: 329-36.
9. Rosenthal DI. Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes. Support Oncol 2007; 5: 23-31.
10. Russo G, Haddad R, Posner M, Machtay M. Radiation treatment breaks and ulcerative mucositis in head and neck cancer. The Oncologist 2008; 13: 886-98.
11. Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury. Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer Suppl 2004; 100: 1995-2025.
12. Sonis ST. Pathobiology of oral mucositis: Novel insights and opportunities. Support Oncol 2007; 5: 3-11.
13. Keefe DM, Schubert MM, Elting LS, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007; 109: 820-31.
14. Silverman SJr. Diagnosis and management of oral mucositis. Support Oncol 2007; 5: 13-21.
15. Teister N, Sonis S. Mucositis: biology and management. Curr Opin Otolaryngol Head Neck Surg 2007; 15: 123-9.
16. Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients with cancer. Dent Clin North Am 2008; 52: 61-77, viii.
17. Spijkervet FKL, Van Saene HKF, Van Saene JJM, et al. Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients. J Surg Oncol 1991; 46: 167-73.
18. El-Sayed S, Nabid A, Shelley W, et al. Prophylaxis of radiationassociated mucositis in conventionally treated patients with head and neck cancer: A double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system. J Clin Oncol 2002; 20: 3956-63.
19. Donelly JP, Bellm LA, Epstein JB, Sonis ST, Symonds RP. Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis 2003; 3: 405-12.
20. Barasch A, Elad S, Altman A, Damato K, Epstein JB. Antimicrobials, mucosal coating agents, anesthetics, and nutritional supplements for alimentary tract mucositis. Support Care Cancer 2006; 14: 528-32.
21. Epstein JB, Freilich MM, Le ND. Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck. Oral Surg Oral Med Oral Pathol 1993; 76: 169-74.
22. Nicolatou-Galitis O, Velegraki A, Sotiropoulou-Lontou A, et al. Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. Support Care Cancer 2006a; 14: 44-51.
23. Nicolatou-Galitis O, Athanassiadou P, Kouloulias V, et al. Herpes simplex virus-1 (HSV-1) infection in radiaton-induced oral mucositis. Support Care Cancer 2006b; 14: 753-62.
24. Nicolatou-Galitis O, Dardoufas K, Markoulatos P, et al. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash. J Oral Pathol Med 2001; 30: 471-80.
25. Dahiya MC, Redding SW, Dahiya RS, et al. Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003; 57: 79-83.
26. Nicolatou-Galitis O, Sotiropoulou-Lontou A, Velegraki A, et al. Oral candidiasis in head and neck cancer patients receiving radiotherapy, with amifostine cytoprotection. Oral Oncol 2003; 39: 397-401.
27. Jham BC, Franca EC, Olivera RR, et al. Candida oral colonization and infection in Brazilian patients undergoing head and neck radiotherapy: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 355-58.
28. Paula CR, Sampaio MCC, Birman E, Siqueira AM. Oral yeasts in patients with cancer of the mouth, before and during radiotherapy. Mycopathologia 1990; 112: 119-24.
29. Mucke R, Kaben U, Libera T, et al. Fluconazole prophylaxis in patients with head and neck tumours undergoing radiation and radiochemotherapy. Mycoses 1998; 41: 421-3.
30. Koc M, Aktas E. Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck cancers. Jpn J Clin Oncol 2003; 33: 57-60.
31. Djuric M, Jankovic L, Jovanovic T, et al. Prevalence of oral herpes simplex virus reactivation in cancer patients: a comparison of different techniques of viral detection. J Oral Pathol Med 2009; 38: 167-73.
32. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-6.
33. Nicolatou-Galitis O, Sarri T, Dardoufas K, et al. Oral mucositis, pain and xerostomia in patients with head and neck cancer who receive chemoradiotherapy with or without cetuximab. Open Clin Cancer J 2010; 4: 6-14.